Ledger.Open graph →
SEC Form D · filed June 17, 2019

Prelude Therapeutics Inc

Offering
$60.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Wilmington, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David Mauro · Wilmington, DEExecPeggy Scherle · Wilmington, DEExecKrishna Vaddi · Chadds Ford, PAExec · DirectorKelvin Neu · San Francisco, CADirectorDavid Bonita · Montreal, Quebec, CanadaDirectorPaul Friedman · New York, NYDirectorKrishna Vaddi · Chadds Ford, PAExec · DirectorDavid Mauro · Wilmington, DEExecPeggy Scherle · Wilmington, DEExecKelvin Neu · Newark, DEDirectorDavid Bonita · New York, NYDirectorPaul Friedman · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗